About Brad Hauser
Form D filings for Candesant Biomedical in 2023 list Brad Hauser as director.
Brad Hauser first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Brad Hauser in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Brad Hauser works with at each company, as listed on that company's latest Form D.
Candesant Biomedical, Inc. · Form D, Jun 6, 2023
KL
Karen Long
Director
NH
Niquette Hunt
President and Chief Executive Officer, director
MK
Mary Beth Kreissler
Executive officer
SB
Samara Braunstein
Director
MK
Michael Kane
Director
EM
Eileen McGuire
Director